Pankova, O. A. (2022). Relaxin-2 as a promising biomarker of cardiometabolic diseases.
Chicago Style (17th ed.) CitationPankova, O. A. Relaxin-2 as a Promising Biomarker of Cardiometabolic Diseases. 2022.
MLA (8th ed.) CitationPankova, O. A. Relaxin-2 as a Promising Biomarker of Cardiometabolic Diseases. 2022.
Warning: These citations may not always be 100% accurate.